MIR6786

Across TCGA pan-cancer cohorts, MIR6786 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR6786 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR6786 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6786 expression acts as an unfavorable survival marker.

CESC, ACC, and CHOL are the cancer types where MIR6786 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.229	0.803	<.001	108	view →
ACC	DFS	Tertile	All	0.046	0.753	<.001	108	view →
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
SKCM	DFS	Tertile	III,IV	0.037	0.597	<.001	42	view →
PCPG	OS	Tertile	All	0.683	0.975	<.001	27	view →
LAML	DFS	Tertile	All	0.132	0.425	.019	18	view →
LUSC	DFS	Tertile	II,III,IV	0.202	0.715	<.001	18	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	18	view →
THCA	DFS	Tertile	III,IV	0.222	0.756	.008	12	view →
ESCA	DFS	Tertile	III,IV	0.100	0.441	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR6786–CESC (OS)

Open the CESC breakdown →